How Saline Infusion Sonohysterography Helps Assess Cesarean Scar Defects
Official title: Preliminary Clinical Application Study of Saline Infusion Onohysterography in Structure of Cesarean Scar Surgery
Run by Tang-Du Hospital · NCT07610668 · Data updated 2026-11-12
This study tests whether saline infusion sonohysterography can reliably detect cesarean scar defects and guide treatment for people experiencing symptoms after cesarean delivery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years to 50 Years |
| Sex | Women only |
| Enrollment | 300 (estimated) |
| Sponsor | Tang-Du Hospital Academic / other |
| Locations | 1 site (Xi'an, Shaanxi) |
| Status | Recruiting |
| Started | January 1, 2023 |
| Main results expected | June 30, 2026 |
| Study ends | July 31, 2026 |
| Registry record updated | May 28, 2026 |
| Trial ID | NCT07610668 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals more than 6 months past cesarean delivery with symptoms such as abnormal bleeding, dysmenorrhea, prolonged spotting, or secondary infertility who need SIS to evaluate the cesarean scar.
✕Probably not a fit
Patients without cesarean scar defects or without symptoms related to the cesarean scar may derive no direct benefit from this SIS-focused assessment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-center observational study investigates the diagnostic value of saline infusion sonohysterography (SIS) in evaluating cesarean scar incision structure. Researchers compare SIS findings with hysteroscopy, MRI, and conventional ultrasound to assess detection of cesarean scar diverticula, changes in diverticulum size, and the residual myometrial thickness. Patients with prior cesarean delivery who require SIS and have related symptoms are followed after diverticulum reconstruction to monitor symptom improvement and prognosis for up to one year. The goal is to determine how SIS can support clinical decision-making and patient outcomes, potentially informing standardized assessment and surgical planning. Safety and data completeness are considered through well-defined inclusion and exclusion criteria and follow-up.
Why it matters
Potential benefit: If successful, SIS could improve preoperative diagnosis and help tailor surgical decisions to improve symptom relief and reduce complications.
How similar studies have gone: Previous research in similar imaging approaches has shown promise in characterizing cesarean scar defects, supporting the potential value of SIS in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * More than 6 months after cesarean delivery; * Presenting with clinical symptoms-including abnormal uterine bleeding, dysmenorrhea, prolonged menstrual spotting, or secondary infertility; * Requiring saline infusion sonohysterography (SIS) to evaluate the cesarean scar. Exclusion Criteria: * Multiple cesarean deliveries; * Patients contraindicated for saline infusion sonohysterography (SIS), including pregnancy or suspected pregnancy, failure to meet vaginal hygiene criteria, inability to cooperate during the procedure, or suboptimal image quality; * Cases with incomplete clinical data or lost to follow-up.
Where it's running
-
Tang-Du Hospital
Xi'an, Shaanxi, China Recruiting
Study contacts
- Principal investigator: Li Zhang, MD — The Second Affiliated Hospital of Air Force Military Medical University
- Study coordinator: Li Zhang, MD
- Email: lilyzhang319_20@hotmail.com
- Phone: 86-29-84778860
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted embryo selection on day 5 in IVF for infertility
This trial tests whether an AI-based embryo selection tool can help pick the best embryo for transfer on day 5 in IVF/ICSI to improve pregnancy chances for people with infertility.
-
Preserving sperm quality with aging through cryopreservation
This study tests whether freezing and thawing sperm can help keep younger-like DNA and molecular traits in men as they age.
-
Unstimulated Egg Retrieval with CAPA-IVM and Euploid Embryo Transfer
This study tests whether eggs can be collected without ovarian stimulation, matured in the lab, and used to create a single euploid embryo for transfer in infertility patients.
-
Ultra-Long GnRH-a Pretreatment Before Frozen Embryo Transfer for Deep Infiltrating Endometriosis
In people under 40 with deep infiltrating endometriosis and infertility, the study tests whether two injections of a GnRH agonist before hormone support improve pregnancy outcomes in their first frozen-thawed embryo transfer.
-
Endometrial Waves and Pregnancy in FET Cycles with Hormone Therapy
This study tests whether patterns of uterine contractions during hormone-prepared frozen embryo transfer affect pregnancy outcomes.
-
Environmental and lifestyle factors linked to ART success in infertility patients
This study follows 5,000 infertile men and women to see how environmental exposures and lifestyle relate to the success of assisted reproductive technology.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.